PT3165222T - Utilização do composto de ftalida - Google Patents

Utilização do composto de ftalida

Info

Publication number
PT3165222T
PT3165222T PT148969470T PT14896947T PT3165222T PT 3165222 T PT3165222 T PT 3165222T PT 148969470 T PT148969470 T PT 148969470T PT 14896947 T PT14896947 T PT 14896947T PT 3165222 T PT3165222 T PT 3165222T
Authority
PT
Portugal
Prior art keywords
phthalide compound
phthalide
compound
Prior art date
Application number
PT148969470T
Other languages
English (en)
Original Assignee
Everfront Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everfront Biotech Inc filed Critical Everfront Biotech Inc
Publication of PT3165222T publication Critical patent/PT3165222T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT148969470T 2014-07-04 2014-07-04 Utilização do composto de ftalida PT3165222T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2014/081678 WO2016000265A1 (zh) 2014-07-04 2014-07-04 苯酞化合物的应用
EP14896947.0A EP3165222B1 (en) 2014-07-04 2014-07-04 Use of phthalide compound

Publications (1)

Publication Number Publication Date
PT3165222T true PT3165222T (pt) 2020-05-14

Family

ID=55018341

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148969470T PT3165222T (pt) 2014-07-04 2014-07-04 Utilização do composto de ftalida

Country Status (7)

Country Link
EP (1) EP3165222B1 (pt)
JP (1) JP6413008B2 (pt)
AU (1) AU2014399624B2 (pt)
ES (1) ES2795696T3 (pt)
NZ (1) NZ728386A (pt)
PT (1) PT3165222T (pt)
WO (1) WO2016000265A1 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002068973A (ja) * 2000-06-16 2002-03-08 Meiji Milk Prod Co Ltd 幹細胞分化誘導促進剤
US7416747B2 (en) * 2000-11-22 2008-08-26 Xia Yongchao Herbal composition for treatment of neurodegeneration and neuronal dysfunction
EP1437410A4 (en) * 2001-09-13 2005-01-26 Juridical Foundation NEW SELENOCYSTEIN CONTAINING PROTEINS
JP4953041B2 (ja) * 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤
CN100435792C (zh) * 2004-04-23 2008-11-26 石药集团中奇制药技术（石家庄）有限公司 丁基苯酞类同系物在制备治疗抗血小板聚集和抗血栓药物中的应用
CN101455661B (zh) * 2008-11-19 2012-10-10 中国科学院上海有机化学研究所 3-取代苯酞及其类似物的用途
EP2343051B1 (en) * 2010-01-05 2014-07-30 National Dong Hwa University Anti-cancer formulation
TWI386203B (zh) * 2011-01-07 2013-02-21 Univ China Medical 治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
JP6087706B2 (ja) * 2012-04-12 2017-03-01 クラシエ製薬株式会社 細胞死抑制組成物
AU2012387970B2 (en) * 2012-08-17 2015-10-29 China Medical University Pharmaceutical composition for inhibiting autophagy of motor neurons and use thereof

Also Published As

Publication number Publication date
NZ728386A (en) 2018-02-23
EP3165222B1 (en) 2020-03-11
JP2017521417A (ja) 2017-08-03
JP6413008B2 (ja) 2018-10-24
AU2014399624A1 (en) 2017-02-09
EP3165222A1 (en) 2017-05-10
WO2016000265A1 (zh) 2016-01-07
EP3165222A4 (en) 2018-01-10
ES2795696T3 (es) 2020-11-24
AU2014399624B2 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
TWI561516B (en) Substituted dihydroisoquinolinone compounds
SG11201706729SA (en) Derivatives of sobetirome
ZA201700880B (en) Polymorphs of selinexor
SG11201609265RA (en) Characterizing states of subject
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201520799D0 (en) None
GB201402431D0 (en) Compounds
SI3154526T1 (sl) Trdne oblike sofosbuvira
GB201406591D0 (en) Compounds
GB201406956D0 (en) Compounds
GB201404987D0 (en) Compounds
IL246979A0 (en) Crystalline forms of sofosbuvir
PL3113773T3 (pl) Krystaliczne postaci grapiprantu
ZA201706282B (en) Solid forms of menaquinols
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
HUS2500045I1 (hu) Etilén-glikolok MMF származékai
GB201407822D0 (en) Use of a composition
IL249130B (en) Preparation of piperidine-4-carbothioamide
GB201407695D0 (en) Compounds
HUP1500506A2 (en) Salts of palbociclib
GB201405361D0 (en) Compounds
IL249332A0 (en) Crystalline forms of sofosbuvir
EP3165222A4 (en) Use of phthalide compound
PL3137475T3 (pl) Oczyszczanie epidaunorubicyny
TWM490331U (en) Improved structure of mask